Happy to share that for the third year in a row, we are in the prestigious Science Magazine annual list of top 20 pharma employers globally. This year, we are placed at number 15, with improved ranking over the past three years. The 2024 SC Top Employer report is based on over 6,400 surveys completed globally among the science, biotech and pharma community to learn about what they value in employers. Thrilled to be rated highly by respondents in the areas of ‘employee respect’, ‘social responsibility’, and ‘employee loyalty’.
We endeavour to offer our colleagues the freedom to pursue multiple career tracks within the organisation and expose them to the best ideas and knowledge in whatever field they choose to work in. Our culture and identity have revolved around being bold, entrepreneurial, responsible, humble, empathetic. Our purpose of ‘Good Health Can’t Wait’ is a movement and call to action for all of us, and good health encompasses patients, people and planet. As our Co-Chairman & MD, G V Prasad notes, “The opportunity is available to each colleague to do their life’s work at our company and make the world a better place. Our people are our pride, and nothing gives us more joy than to see our people realise their full potential in the company.”
Deep science and progressive people practices continue to be core tenets of our company. A recent report by the Foundation for Advancing Science and Technology (FAST India) in collaboration with IIFL Securities on ‘State of Industry R&D in India’ ranked Dr. Reddy’s first among Indian pharma companies in both R&D intensity and the proportion of PhD employees. Such recognitions only strengthen our resolve to continue to be an attractive destination for talent in science through our work.
For more information, visit the Science website here: https://bit.ly/4eTXBBp or read our announcement here: http://bit.ly/3BXuBdb
